Overall survival | Progression-free survival | |||||||
---|---|---|---|---|---|---|---|---|
Characteristics | Univariate | Multivariate | Univariate | Multivariate | ||||
HR(95% CI) | P value | HR(95% CI) | P value | HR(95% CI) | P value | HR(95% CI) | P value | |
Age (≥60y vs < 60y) | 1.550 (0.681–3.525) | 0.296 | 1.251 (0.599–2.615) | 0.551 | ||||
Gender (Male vs Female) | 0.995 (0.409–2.424) | 0.992 | 0.958 (0.435–2.110) | 0.915 | ||||
WHO/ISUP Grading (III-IV vs I-II) | 3.804 (1.645–8.795) | 0.002 | 1.412 (0.595–3.352) | 0.434 | 2.148 (1.032–4.469) | 0.041 | 1.079 (0.499–2.333) | 0.846 |
TNM stage (III-IV vs I-II) | 5.843 (2.222–15.363) | < 0.001 | 3.028 (1.115–8.222) | 0.03 | 9.042 (4.157–19.667) | < 0.001 | 5.441 (2.329–12.712) | < 0.001 |
SSIGN (≥5 vs 1–4) | 9.235 (3.881–21.975) | < 0.001 | 2.635 (1.058–6.562) | 0.037 | 17.907 (8.057–39.800) | < 0.001 | 7.604 (3.169–18.243) | < 0.001 |
HECW1 (High vs Low) | 51.099 (6.841–381.667) | < 0.001 | 29.907 (3.750–238.530) | 0.001 | 10.054 (4.183–26.373) | < 0.001 | 5.072 (1.728–14.891) | 0.003 |